Prodromal dysimmunity in cancer. Pathophysiology of pre- and perineoplastic immune deficiency disorders that may represent syndromes of transition from dysimmunity to cancer.
D000328:Adult; D001195:Asbestosis; D001327:Autoimmune Diseases; D001796:Blood Protein Disorders; D003874:Dermatitis Herpetiformis; D003873:Dermatitis, Exfoliative; D005260:Female; D006099:Granuloma; D006648:Histocompatibility; D006801:Humans; D007154:Immune System Diseases; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes; D007165:Immunosuppression Therapy; D007642:Keratosis; D008113:Liver Neoplasms / Q000276:immunology; D008171:Lung Diseases; D008206:Lymphatic Diseases; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology*; D011230:Precancerous Conditions; D012878:Skin Neoplasms / Q000276:immunology; D013577:Syndrome; D013601:T-Lymphocytes